Cargando…

CD73, Tumor Plasticity and Immune Evasion in Solid Cancers

SIMPLE SUMMARY: Tumors are ecosystems composed of cancer cells and non-tumor stroma together in a hypoxic environment often described as wounds that do not heal. Accumulating data suggest that solid tumors hijack cellular plasticity possibly to evade detection by the immune system. CD73-mediated gen...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Haitang, Yao, Feng, Davis, Paul F., Tan, Swee T., Hall, Sean R. R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825701/ https://www.ncbi.nlm.nih.gov/pubmed/33430239 http://dx.doi.org/10.3390/cancers13020177

Ejemplares similares

NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma
por: Yang, Haitang, et al.
Publicado: (2021)

Is CD47 an innate immune checkpoint for tumor evasion?
por: Liu, Xiaojuan, et al.
Publicado: (2017)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

Peritumoral CD90+CD73+ cells possess immunosuppressive features in human non-small cell lung cancer
por: Wang, Limei, et al.
Publicado: (2021)

P818: DNP73 PROMOTES DRUG RESISTANCE AND IMMUNE EVASION IN MULTIPLE MYELOMA BY MODULATING MYC/CD47 AXIS
por: Liu, Lanting, et al.
Publicado: (2023)

Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
por: Chambers, Andrea M, et al.
Publicado: (2022)

The CD73 immune checkpoint promotes tumor cell metabolic fitness
por: Allard, David, et al.
Publicado: (2023)

Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
por: Chambers, Andrea M., et al.
Publicado: (2019)

A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape
por: Kellner, Markus, et al.
Publicado: (2022)

Targeting CD73 in the tumor microenvironment with MEDI9447
por: Hay, Carl M., et al.
Publicado: (2016)

The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ Transplantation
por: Roberts, Veena, et al.
Publicado: (2014)

Enhanced expression of CD39 and CD73 on T cells in the regulation of anti-tumor immune responses
por: Shevchenko, Ivan, et al.
Publicado: (2020)

Overexpression of CD200 is a stem cell-specific mechanism of immune evasion in AML
por: Herbrich, Shelley, et al.
Publicado: (2021)

Prognositic value of CD73-adenosinergic pathway in solid tumor: A meta-analysis and systematic review
por: Wang, Rong, et al.
Publicado: (2017)

Targeting CD73 with AB680 (Quemliclustat), a Novel and Potent Small-Molecule CD73 Inhibitor, Restores Immune Functionality and Facilitates Antitumor Immunity
por: Piovesan, Dana, et al.
Publicado: (2022)

Acetylation in Tumor Immune Evasion Regulation
por: Lu, Jun, et al.
Publicado: (2021)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
por: Zhang, Lian, et al.
Publicado: (2023)

Engineering immune evasion
por: Mascola, John R.
Publicado: (2006)

Intra-tumoral production of IL18, but not IL12, by TCR-engineered T cells is non-toxic and counteracts immune evasion of solid tumors
por: Kunert, A., et al.
Publicado: (2017)

Physiological roles for ecto-5’-nucleotidase (CD73)
por: Colgan, Sean P., et al.
Publicado: (2006)

Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
por: Ploeg, Emily Maria, et al.
Publicado: (2023)

CD8(+) T-cell Immune Evasion Enables Oncolytic Virus Immunotherapy
por: Pourchet, Aldo, et al.
Publicado: (2016)

TSH-TSHR axis promotes tumor immune evasion
por: Wu, Zhenghao, et al.
Publicado: (2022)

PD-L1 on tumor cells is sufficient for immune evasion in immunogenic tumors and inhibits CD8 T cell cytotoxicity
por: Juneja, Vikram R., et al.
Publicado: (2017)

Overcoming tumor immune evasion with an unique arbovirus
por: Lyday, Bruce, et al.
Publicado: (2015)

Structural Plasticity and Immune Evasion of SARS-CoV-2 Spike Variants
por: Ghimire, Dibya, et al.
Publicado: (2022)

Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer
por: Kowash, Ryan R., et al.
Publicado: (2023)

Immune Evasion Strategies of Schistosomes
por: Hambrook, Jacob R., et al.
Publicado: (2021)

The Roles of CD73 in Cancer
por: Gao, Zhao-wei, et al.
Publicado: (2014)

Lymphoma: Immune Evasion Strategies
por: Upadhyay, Ranjan, et al.
Publicado: (2015)

Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
por: Zelenay, Santiago, et al.
Publicado: (2015)

Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
por: Castro, Flávia, et al.
Publicado: (2018)

Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
por: Hilmi, Marc, et al.
Publicado: (2020)

SNAIL1: Linking Tumor Metastasis to Immune Evasion
por: Tang, Xiaolong, et al.
Publicado: (2021)

Tumor microenvironment-mediated immune evasion in hepatocellular carcinoma
por: Chen, Chen, et al.
Publicado: (2023)

Peroxynitrite promotes immune evasion by reducing tumor antigenicity
por: Capietto, Aude-Hélène, et al.
Publicado: (2022)

Battles against aberrant KEAP1-NRF2 signaling in lung cancer: intertwined metabolic and immune networks
por: Xu, Ke, et al.
Publicado: (2023)

High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
por: Aliagas, Elisabet, et al.
Publicado: (2014)

Tumor Infiltration with CD20(+)CD73(+) B Cells Correlates with Better Outcome in Colorectal Cancer
por: Hansen, Frederik J., et al.
Publicado: (2022)

Four hub genes regulate tumor infiltration by immune cells, antitumor immunity in the tumor microenvironment, and survival outcomes in lung squamous cell carcinoma patients
por: Zhang, Tuo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v716gst27d7gbqepfl81aab4a0